[New drugs for the therapy of acute leukemia].
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use; D003561:Cytarabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003630:Daunorubicin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006144:Guanazole / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008130:Lomustine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010440:Peptichemio / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000031:analogs & derivatives; D011929:Razoxane / Q000627:therapeutic use; D009353:Zinostatin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003561:Cytarabine; D011929:Razoxane; D008130:Lomustine; D004317:Doxorubicin; D009353:Zinostatin; D010440:Peptichemio; D006144:Guanazole; D011034:Podophyllotoxin; D001374:Azacitidine; D003630:Daunorubicin
Farmaci nuovi per la terapia della leucemia acuta